A Pilot, Open-Label Study to Determine the Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia

Kelly L. Sullivan

A Pilot, Open-Label Study to Determine the Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia

Biostatistics, Epidemiology, & Environmental Health Sciences

Research output: Other contribution › Other

Original language	American English
State	Published - 2011

DC Disciplines

Epidemiology
Public Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{b407a762e3de479e8ce99f18f7e4f5b6,

title = "A Pilot, Open-Label Study to Determine the Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia",

author = "Sullivan, {Kelly L.}",

note = "Kelly L. Sullivan (Project Manager & Epidemiologist), {"}A Pilot, Open-Label Study to Determine the Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia,{"} Baxter. (2011-present).",

year = "2011",

language = "American English",

type = "Other",

}

TY - GEN

T1 - A Pilot, Open-Label Study to Determine the Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia

AU - Sullivan, Kelly L.

N1 - Kelly L. Sullivan (Project Manager & Epidemiologist), "A Pilot, Open-Label Study to Determine the Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia," Baxter. (2011-present).

PY - 2011

Y1 - 2011

M3 - Other

ER -